Aseptic Packaging (US Market & Forecast)
|出版日||ページ情報||英文 218 Pages
|無菌包装の米国市場 Aseptic Packaging (US Market & Forecast)|
|出版日: 2016年03月28日||ページ情報: 英文 218 Pages||
当レポートでは、米国における無菌包装の需要実績データ (2005年、2010年、2015年) と今後の予測 (2020年、2025年) を製品および市場別に提供しており、市場環境要因の考察や主要企業の市場シェアとプロファイル、産業構造の分析などとともにお届けします。
US aseptic packaging demand is forecast to reach $6.4 billion in 2020, with growth outpacing that of the overall packaging industry. Advances will be fueled by drug sterility requirements and by ambient distribution and storage advantages for food and beverages. Specifically, the increasing availability of biotechnology-based injectable drugs necessitates aseptic filling and packaging, as such drugs tend to be heat sensitive, making the high heat used in terminal sterilization processes unfeasible. The shelf stability of aseptic packaging will fuel rapid growth in dairy-based food and beverages as it enables these perishable products to have a longer shelf life and be distributed in an unrefrigerated condition.
Pharmaceuticals are the largest market for aseptic packaging and market growth will reflect the broadening availability and consumption of biotechnology-based drugs, along with aseptic filling requirements of other liquid pharmaceuticals. Biotechnology-based drugs tend to be heat sensitive and are thus unable to withstand the high heat of terminal sterilization processes. In addition, opportunities will be apurred by preferences among healthcare providers for unit-dose delivery formats, such as vials, ampuls, prefillable syringes, and premixed IV solutions, as these formats provide better efficiency and dosing accuracy. Gains in pharmaceutical uses will also be supported by increased use of advanced aseptic processes, such as blow-fill-seal (BFS). In contrast to traditional aseptic processing, BFS enables the molding, filling, and hermetic sealing of vials and bottles in a continuous automated process without human intervention, resulting in a high assurance of product sterility.
Prefillable syringes will represent the fastest growing aseptic packaging product type through 2020, the result of advances in life sciences leading to a broader range of biotechnology-based injectable drugs. Increases will also reflect safety and convenience advantages of prefillable syringes and the prevalence of chronic conditions necessitating lifetime drug regimens. Prospects for aseptic cartons will be fueled by expanding liquid food and dairy beverage applications and innovations that enable aseptic filling of liquid and viscous foods with particulates. Other factors supporting growth include improving aesthetics of cartons, cost benefits, a favorable environmental profile, a premium image, the availability of cartons with closures, and the appeal of nontraditional packaging among younger consumers. Growth for aseptically filled plastic bottles will be the result of expanding food and beverage applications and ongoing opportunities in the pharmaceutical market. In the beverage market, increased adoption of aseptic filling of low-acid beverages is expected, as it enables shelf-stable distribution and storage of these products. Additionally, bottle opportunities will be helped by favorable consumption trends for preservative-free premium beverages, such as fruit and tea blends, and protein shakes, which can experience flavor changes and nutrient loss when exposed to the high heat of hot-fill bottling.
This Freedonia industry study, Aseptic Packaging, presents historical demand data (2005, 2010 and 2015) and forecasts (2020 and 2025) by product and market. The study also assesses market environment factors, evaluates company market share, and profiles 36 US industry players such as West Pharmaceutical Services, Baxter International, Becton Dickinson, Scholle, Reynolds Group, Nestlé, Onex and Tetra Laval International.